Section 7: Myelofibrosis: Lymphomas during JAK inhibitor therapy?​

Prof. Heinz Gisslinger (Program Director MPN, Department for Hematology and Blood Coagulation, Medical University of Vienna)

Section 7: Myelofibrosis: Lymphomas during JAK inhibitor therapy?

Recorded: 14. Nov 2019

Related items